Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07273942

Remote Ischemic Postconditioning in Septic Shock

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
720 (estimated)
Sponsor
Hospices Civils de Lyon · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Septic shock is a leading cause of death worldwide despite intensive research efforts. Only a few interventions have been proven to be effective in improving patient-centered outcomes. Recent clinical trials have reported the safety and efficacy of remote ischemic postconditioning (RIPOST) in a variety of pathologies, including myocardial infarction, cardiac surgery, and stroke. While RIPOST was mainly tested in pathologies with low mortality rates, several follow-up studies of large randomized clinical trials in acute myocardial infarction and in patients undergoing coronary artery bypass surgery have reported significant decreases (\> 50%) in long-term mortality. Experimental studies and proof-of-concept clinical trials have also suggested the potential benefits of RIPOST on mortality in sepsis and septic shock. The present protocol aims to test whether this non-invasive, widely available, inexpensive, and innovative intervention can improve survival in septic shock.

Conditions

Interventions

TypeNameDescription
OTHERRemote ischemic conditioningA brachial cuff is positioned around one arm of the patient. Remote ischemic conditioning consists of alternating inflations and deflations of the brachial cuff. Four cycles of ischemic conditioning (5-min brachial cuff inflation at 200 mmHg followed by 5-min cuff deflation) are started as soon as possible after inclusion. The intervention is repeated 12 and 24 hours after inclusion.
OTHERNo interventionNo intervention will be performed in the conrol group

Timeline

Start date
2026-04-01
Primary completion
2028-07-01
Completion
2028-07-01
First posted
2025-12-10
Last updated
2026-01-28

Locations

23 sites across 1 country: France

Source: ClinicalTrials.gov record NCT07273942. Inclusion in this directory is not an endorsement.